Pacira gains as Wedbush initiates at Outperform seeing attractive entry point

Jan. 31, 2023 10:52 AM ETPacira BioSciences, Inc. (PCRX)By: Dulan Lokuwithana, SA News Editor

Wall street sign in New York with New York Stock Exchange background

naphtalina/iStock via Getty Images

  • The shares of pain therapy developer Pacira BioSciences (NASDAQ:PCRX) gained in the morning hours Tuesday after Wedbush Securities started its coverage with an Outperform recommendation citing a compelling buying opportunity.
  • Pacira (PCRX) has lost

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.